Veterinary Medicine Information website

Ataxxa 200 mg/40 mg spot-on solution for dogs up to 4 kg

Authorised
  • Permethrin
  • Imidacloprid
Download as PDF

Product identification

Medicine name:
Ataxxa 200 mg/40 mg spot-on solution for dogs up to 4 kg
Active substance:
  • Permethrin
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Permethrin
    200.00
    milligram(s)
    /
    1.00
    Pipette
  • Imidacloprid
    40.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.1 ml pipette containing 0.4 ml of solution. Box containing 10 pipettes.
  • White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.1 ml pipette containing 0.4 ml of solution. Box containing 6 pipettes.
  • White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.1 ml pipette containing 0.4 ml of solution. Box containing 4 pipettes.
  • White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.1 ml pipette containing 0.4 ml of solution. Box containing 3 pipettes.
  • White polypropylene pipette closed with a polyoxymethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.1 ml pipette containing 0.4 ml of solution. Box containing 1 pipette.
  • White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.1 ml pipette containing 0.4 ml of solution. Box containing 1 pipette.
  • White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.1 ml pipette containing 0.4 ml of solution. Box containing 3 pipettes.
  • White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.1 ml pipette containing 0.4 ml of solution. Box containing 4 pipettes.
  • White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.1 ml pipette containing 0.4 ml of solution. Box containing 6 pipettes.
  • White polypropylene pipette closed with a polyethylene cap. Each pipette is packed in apolyethylene terephthalate/aluminium/low density polyethylene triplex bag.1 ml pipette containing 0.4 ml of solution. Box containing 10 pipettes.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • TAD Pharma GmbH
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 115886
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0439/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Estonia
  • France
  • Germany
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 15/08/2023
Updated on: 16/08/2023
Download

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download